Cargando…

CSMD1 Mutation Related to Immunity Can Be Used as a Marker to Evaluate the Clinical Therapeutic Effect and Prognosis of Patients with Esophageal Cancer

INTRODUCTION: As a highly aggressive tumor with a poor prognosis, esophageal cancer (ESCA)’s relationship with gene mutations is unclear. Therefore, we tried to explore the role of gene mutation in ESCA progression and its relationship with immune response, clinical treatment, and prognosis. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Xin, Song, Jianxiong, Fan, Yating, Li, Jiaqi, Chen, Yutao, Zhu, Huanhuan, Zhang, Zhiyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627272/ https://www.ncbi.nlm.nih.gov/pubmed/34849012 http://dx.doi.org/10.2147/IJGM.S338284

Ejemplares similares

CSMD1 Mutations Are Associated with Increased Mutational Burden, Favorable Prognosis, and Anti-Tumor Immunity in Gastric Cancer
por: Huang, Taobi, et al.
Publicado: (2021)

CSMD3 is Associated with Tumor Mutation Burden and Immune Infiltration in Ovarian Cancer Patients
por: Lu, Nan, et al.
Publicado: (2021)

Rare mutations in the complement regulatory gene CSMD1 are associated with male and female infertility
por: Lee, Arthur S., et al.
Publicado: (2019)

Association of CSMD1 with Tumor Mutation Burden and Other Clinical Outcomes in Gastric Cancer
por: Wang, Xuning, et al.
Publicado: (2021)

A new marker constructed from immune-related lncRNA pairs can be used to predict clinical treatment effects and prognosis: in-depth exploration of underlying mechanisms in HNSCC
por: Fan, Xin, et al.
Publicado: (2023)

Loss of CSMD1 disrupts mammary epithelial morphogenesis
por: Kamal, M, et al.
Publicado: (2010)

The Role of Csmd1 during Mammary Gland Development
por: Burgess, Samuel J., et al.
Publicado: (2021)

Whole-exome sequencing associates novel CSMD1 gene mutations with familial Parkinson disease
por: Ruiz-Martínez, Javier, et al.
Publicado: (2017)

Integrated pan-cancer analysis of CSMD2 as a potential prognostic, diagnostic, and immune biomarker
por: Zhang, Huiyun, et al.
Publicado: (2022)

Neuropsychological Deficits in Mice Depleted of the Schizophrenia Susceptibility Gene CSMD1
por: Steen, Vidar M., et al.
Publicado: (2013)

Assessment of Behaviors Modeling Aspects of Schizophrenia in Csmd1 Mutant Mice
por: Distler, Margaret G., et al.
Publicado: (2012)

Altered expression of the CSMD1 gene in the peripheral blood of schizophrenia patients
por: Liu, Yansong, et al.
Publicado: (2019)

Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with CSMD3 mutation
por: Terzic, Julie, et al.
Publicado: (2020)

Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
por: Escudero-Esparza, Astrid, et al.
Publicado: (2016)

Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines
por: Richter, Toni M, et al.
Publicado: (2005)

Genetic Variants in CSMD1 Gene Are Associated with Cognitive Performance in Normal Elderly Population
por: Stepanov, Vadim, et al.
Publicado: (2017)

The Diverse Role of CUB and Sushi Multiple Domains 1 (CSMD1) in Human Diseases
por: Ermis Akyuz, Esra, et al.
Publicado: (2022)

Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
por: Escudero-Esparza, Astrid, et al.
Publicado: (2023)

CSMD1 Shows Complex Patterns of Somatic Copy Number Alterations and Expressions of mRNAs and Target Micro RNAs in Esophageal Squamous Cell Carcinoma
por: Hu, Nan, et al.
Publicado: (2022)

Csmd2 Is a Synaptic Transmembrane Protein that Interacts with PSD-95 and Is Required for Neuronal Maturation
por: Gutierrez, Mark A., et al.
Publicado: (2019)

LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling
por: Liu, Ji, et al.
Publicado: (2020)

No association between the rs10503253 polymorphism in the CSMD1 gene and schizophrenia in a Han Chinese population
por: Liu, Yansong, et al.
Publicado: (2016)

FAT3 Mutation Is Associated With Tumor Mutation Burden and Poor Prognosis in Esophageal Cancer
por: Guo, Zixin, et al.
Publicado: (2021)

Combined identification of ARID1A, CSMD1, and SENP3 as effective prognostic biomarkers for hepatocellular carcinoma
por: Zhao, Yuanyuan, et al.
Publicado: (2021)

Reassessment of oxidative stress in idiopathic sudden hearing loss and preliminary exploration of the effect of physiological concentration of melatonin on prognosis
por: Song, Jianxiong, et al.
Publicado: (2023)

PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer
por: Li, Xinwei, et al.
Publicado: (2022)

CD68 and interleukin 13, prospective immune markers for esophageal squamous cell carcinoma prognosis prediction
por: Li, Jian, et al.
Publicado: (2016)

Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Immunophenotypes and Immune Markers Associated with Acute Promyelocytic Leukemia Prognosis
por: Xu, Fang, et al.
Publicado: (2014)

Somatic Mutations, Allele Loss, and DNA Methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) Gene Reveals Association with Early Age of Diagnosis in Colorectal Cancer Patients
por: Shull, Austin Y., et al.
Publicado: (2013)

Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy
por: Gialeli, Chrysostomi, et al.
Publicado: (2021)

Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability
por: Hatzimanolis, Alex, et al.
Publicado: (2022)

The TP53-Related Signature Predicts Immune Cell Infiltration, Therapeutic Response, and Prognosis in Patients With Esophageal Carcinoma
por: Zhang, Hongpan, et al.
Publicado: (2021)

Biomarkers for Early Detection, Prognosis, and Therapeutics of Esophageal Cancers
por: Rai, Vikrant, et al.
Publicado: (2023)

Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer
por: Li, DaPeng, et al.
Publicado: (2019)

Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1
por: Xu, Wei, et al.
Publicado: (2014)

Deregulation of CSMD1 targeted by microRNA-10b drives gastric cancer progression through the NF-κB pathway
por: Chen, Xiang-Liu, et al.
Publicado: (2019)

New Insight into the human genetic diversity in North African populations by genotyping of SNPs in DRD3 , CSMD1 and NRG1 genes
por: Mestiri, Souhir, et al.
Publicado: (2022)

Correction: Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy
por: Gialeli, Chrysostomi, et al.
Publicado: (2023)

The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivo by mediating apoptosis and autophagy through regulation of the PI3K/Akt/mTOR pathway
por: Liu, Huanhuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a34aj7flib2m135kjs9di8rtfb